In Case You Missed It: Webinar on Safety Assessment of Gene Therapy Products


If you missed our latest webinar titled Nonclinical Safety Assessment of Gene Therapy Products, it’s not too late! The on-demand version is now available.

Topics covered include:

•    current trends in the development of gene therapy products;
•    timing of biodistribution studies based on the ICH S12 Guideline;
•    planning considerations and requirements for toxicity studies; and
•    AAVs NAbs pre-dose screening data for animal selection.

Watch it now!

If you have questions about your nonclinical cell and gene therapy studies, speak with one of our experts.

You may also be interested in:
eBook: Key Considerations for Cell and Gene Therapy Nonclinical Studies
Scientific Poster: Gene Therapy Utilizing Adeno-Associated Viral (AAV) Vectors
Scientific Journal: Applications of PCR Analysis for Your Gene Therapy Programs